京东健康1Q25总收入166亿元，同比+25.5%，对比3Q24/4Q24收入增速14.8/11.3%有较明显提速，我们认为主要反映流感错期带来的用药需求增长，以及保健、器械等品类消费需求的恢复；非IFRS净利润17.7亿元，对应非IFRS净利率10.6%，同比+1.6pp，达到过去两年单季度最高值，主要得益于相对高利润率的保健品业务增速修复及自营业务规模效益的进一步释放。考虑到公司致力于在...
Source Link京东健康1Q25总收入166亿元，同比+25.5%，对比3Q24/4Q24收入增速14.8/11.3%有较明显提速，我们认为主要反映流感错期带来的用药需求增长，以及保健、器械等品类消费需求的恢复；非IFRS净利润17.7亿元，对应非IFRS净利率10.6%，同比+1.6pp，达到过去两年单季度最高值，主要得益于相对高利润率的保健品业务增速修复及自营业务规模效益的进一步释放。考虑到公司致力于在...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.